Chemoimmunotherapy with inotuzumab ozogamicin combined with mini‐hyper‐CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome–negative acute lymphoblastic leukemia in first salvage
暂无分享,去创建一个
M. Konopleva | H. Kantarjian | G. Garcia-Manero | J. Cortes | Xuelin Huang | T. Kadia | F. Ravandi | E. Jabbour | S. O'brien | J. Burger | J. Khoury | N. Jain | N. Short | J. Jorgensen | P. Kebriaei | K. Sasaki | R. Garris | J. Jacob | Maria R. Khouri | Kathryn S. Montalbano | Rebecca E. Garris